We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.
- Authors
Sokal, Etienne M; Hoppenbrouwers, Karel; Vandermeulen, Corinne; Moutschen, Michel; Léonard, Philippe; Moreels, Andre; Haumont, Michèle; Bollen, Alex; Smets, Françoise; Denis, Martine
- Abstract
To date, there is no commercially available vaccine to prevent infectious mononucleosis, a disease frequently induced by Epstein-Barr virus (EBV) infection in adolescents or adults devoid of preexisting immunity to the virus.
- Publication
The Journal of infectious diseases, 2007, Vol 196, Issue 12, p1749
- ISSN
0022-1899
- Publication type
Journal Article
- DOI
10.1086/523813